Rapid-acting insulin analog
This page covers all Rapid-acting insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor, insulin receptor, Insulin receptor (IR).
Targets
Insulin receptor · insulin receptor · Insulin receptor (IR)
Marketed (19)
- Insulin Aspart (IAsp) · University of Aarhus · Diabetes
Insulin aspart is a rapid-acting insulin analog that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues. - Insulin aspart (NovoRapid®) · Novo Nordisk A/S · Diabetes
Insulin aspart is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to promote glucose uptake and lower blood glucose levels. - Insulin lispro (Humalog) · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. - insulin lispro MM · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues. - Insulin Fiasp · Boston Medical Center · Diabetes
Insulin Fiasp is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to facilitate glucose uptake and lower blood sugar. - Insulin, Asp(B28)- · Oxford University Hospitals NHS Trust · Diabetes
Insulin Asp(B28) is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization for energy and storage. - Ultra Rapid Lispro (URLi) · Tel-Aviv Sourasky Medical Center · Diabetes
Ultra Rapid Lispro is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - CSII(insulin Lispro) · The First Affiliated Hospital of Xiamen University · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Faster Insulin Aspart (Fiasp®) · Mountain Diabetes and Endocrine Center · Diabetes
Faster insulin aspart is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Insulin Lispro-aabc · Eli Lilly and Company · Diabetes
Insulin Lispro-aabc is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - Lispro-insulin · University of Roma La Sapienza · Diabetes
Lispro-insulin is a rapid-acting insulin analog that binds to insulin receptors to promote glucose uptake and utilization in peripheral tissues. - Prandial Insulin Lispro · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to promote glucose uptake and lower blood sugar levels. - Fiasp® · Novo Nordisk A/S · Diabetes
Fiasp is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - INSULIN GLULISINE (HMR1964) · Sanofi · Diabetes
Insulin glulisine is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - Apidra (insulin glulisine) · Sanofi · Diabetes
Insulin glulisine is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to promote glucose uptake and lower blood glucose levels. - aspart insulin or lipro insulin · Nanjing First Hospital, Nanjing Medical University · Diabetes
Aspart insulin is a rapid-acting insulin analog that binds to insulin receptors to promote glucose uptake and utilization in peripheral tissues. - Humalog Kwikpen · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Diabetes
Humalog is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells. - Insulin lispro A · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization for blood sugar control. - Insulin Lispro low mixture · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to promote glucose uptake and lower blood glucose levels.
Phase 3 pipeline (19)
- Insulin lispro 6 day reservoir in-use · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Insuline Glulisine · Sanofi · Diabetes
Insulin glulisine is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to promote glucose uptake and lower blood glucose levels. - Insulin glulisine QD · Sanofi · Diabetes
Insulin glulisine is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to facilitate glucose uptake and lower blood glucose levels. - Insulin lispro 2 day reservoir in-use · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Insulin aspart 6 day reservoir in-use · Eli Lilly and Company · Diabetes
Insulin aspart is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Insulin aspart SAR341402 · Sanofi · Diabetes
Insulin aspart SAR341402 is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - Faster-acting insulin aspart · Novo Nordisk A/S · Diabetes
Faster-acting insulin aspart is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - NovoLog/NovoRapid · Sanofi · Diabetes
NovoLog/NovoRapid is a rapid-acting insulin analog that mimics the action of natural insulin to lower blood glucose levels. - Control (insulin Novorapid) · Rigshospitalet, Denmark · Diabetes
Insulin aspart (NovoRapid) is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization. - Faster-acting Aspart insulin Fiasp · Rigshospitalet, Denmark · Diabetes
Fiasp is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - Insulin Asparte · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Diabetes
Insulin aspart is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization. - Insulin glulisine TID · Sanofi · Diabetes
Insulin glulisine is a rapid-acting insulin analog that binds to insulin receptors on muscle and fat cells to facilitate glucose uptake and lower blood glucose levels. - NovoRapid® Penfill® · Geropharm · Diabetes
NovoRapid is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells. - Insulin Lispro (U100) · Eli Lilly and Company · Diabetes
Insulin lispro is a rapid-acting insulin analog that binds to insulin receptors on cells to promote glucose uptake and utilization for blood sugar control. - Ultra-Rapid Lispro · Eli Lilly and Company · Diabetes
Ultra-Rapid Lispro is a rapid-acting insulin analog that works by stimulating insulin release from the pancreas. - Insulin Lispro 6 Day (6D) · Eli Lilly and Company · Diabetes
Insulin Lispro 6 Day is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. - Faster aspart · Novo Nordisk A/S · Diabetes
Faster aspart is a rapid-acting insulin analog that binds to the insulin receptor to facilitate glucose uptake and utilization in peripheral tissues. - FlexPen NovoLog® · Mylan Inc. · Diabetes
NovoLog is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells. - LY900014 · Eli Lilly and Company · Diabetes
LY900014 is a rapid-acting insulin lispro formulation that mimics endogenous insulin by binding to insulin receptors to facilitate glucose uptake and metabolism.
Phase 2 pipeline (1)
- Insulin Faster Aspart · Jesús Moreno Fernández · Diabetes
Insulin Faster Aspart is a rapid-acting insulin analog that mimics the action of natural insulin to lower blood glucose levels.
Patent intelligence
- rapid acting insulin analog patent landscape — aggregated cliff calendar, attackable patents, originator estates